Apoptosis as a Target for Gene Therapy in Rheumatoid Arthritis

Memorias do Instituto Oswaldo Cruz

Volumn 95, Issue SUPPL. 1, 2000, Pages 225-233

  Rabinovich, Gabriel Adrián ^a  

^a HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

Author keywords

Apoptosis; Galectin 1; Gene therapy; Rheumatoid arthritis

Indexed keywords

BIOLOGICAL MARKER; CYTOKINE; GALECTIN; HEMAGGLUTININ;

APOPTOSIS; ARTICLE; GENE THERAPY; GENE TRANSFER; GENETICS; HUMAN; IMMUNOLOGY; METHODOLOGY; PHYSIOLOGY; RHEUMATOID ARTHRITIS;

APOPTOSIS; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; CYTOKINES; GALECTINS; GENE THERAPY; GENE TRANSFER TECHNIQUES; HEMAGGLUTININS; HUMANS;

EID: 0033655125     PISSN: 00740276     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0074-02762000000700038     Document Type: Article

References (56)

1. Apparailly F, Verwaerde C, Jackquest C, Auriault C, Sany J, Jorgensen C 1998. Adenovirus-mediated transfer of viral IL-10 gene inhibits murine collagen- induced arthritis. J Immunol 160: 5213-5220.
2. Baum LG, Pang M, Perillo NL, Wu T, Delegaene A, Uittenbogaart CH, Fukuda M, Seihamer JJ 1995. Human thymic epithelial cells express an endogenous lectin, galectin-1, which binds to core 2 O-glycans on thymocytes and T lymphoblastoid cells. J Exp Med 181: 877-887.
3. Bessis N, Boissier MC, Ferrara P, Blankenstein T, Fradelizi D, Fournier C 1996. Attenuation of collagen-induced arthritis in mice by treatment with vector cells engineered to secrete interleukin-13. Eur J Immunol 26: 2399-2403.
4. Beutler E 1999. Gene therapy. Biol Bone Marrow Transplant 5: 273-276.
5. Blaser C, Kaufmann M, Muller C, Zimmerman C, Wells V, Mallucci L, Pircher H 1998. Beta-galactoside-binding protein secreted by activated T cells inhibits antigen-induced proliferation of T cells. Eur J Immunol 28: 2311-2319.
6. Boyle DL, Nguyen KHY, Zhuang S, Shi Y, McCormack JE, Chada S, Firestein GS 1999. Intra-articular IL-4 gene therapy in arthritis: anti-inflammatory effect and enhanced Th2 activity. Gene Ther 6: 1911-1918.
7. Butler DM, Malfait AM, Mason LJ, Warden PJ, Kollias G, Maini RN, Feldmann M, Brennan F 1997. DBA/ 1 mice expressing human TNF-a transgene develop a severe, erosive arthritis. Characterization of the cytokine cascade and cellular components. J Immunol 159: 2867-2876.
8. Chernajovsky Y, Adams G, Triantaphyllopoulos K, Ledda MF, Podhajcer OL 1997. Pathogenic lymphoid cells engineered to express TGF-β1 ameliorate disease in a collagen-induced arthritis model. Gene Ther 4: 553-559.
9. Chernajovsky Y, Adams G, Podhajcer OL, Mueller GM, Robbins PD, Feldmann M 1995a. Inhibition of transfer of collagen-induced arthritis into SCID mice by ex vivo infection of spleen cells with retroviruses expressing soluble tumor necrosis factor receptor. Gene Ther 2: 731-735.
10. Chernajovsky Y, Annenkov A, Herman C, Triantaphyllopoulos, Gould D, Dreja H, Moyes SP, Croxford JL, Mageed RA, Podhajcer OL, Baker D 1998. Gene therapy for rheumatoid arthritis: theoretical considerations. Drugs Aging 12: 29-41.
11. Chernajovsky Y, Feldmann M, Maini RN 1995b. Gene therapy of rheumatoid arthritis via cytokine regulation: future perspectives. Br Med Bull 51: 503-516.
12. Chernajovsky Y, Gould D, Annenkov A, Dreja H, Daly G, Rabinovich GA, Croxford D, Berenstein M, Podhajcer OL 1999. Immunotherapy of autoimmune disease by gene transfer. Biochem Soc Trans 27: 869-873.
13. Courtenay JS, Dallman MJ, Dayan AD, Martin A, Mosedale B 1980. Immunisation against heterologous type II collagen-induced arthritis in mice. Nature 283: 666-668.
14. Dayer JM 1997. Regulation of IL-1/TNF, their natural inhibitors and other cytokines in chronic inflammation. The Immunologist 5: 192-197.
15. Elliot M, Maini RN, Feldmann M 1994. Randomised double blind comparison of a chimeric monoclonal antibody to tumor necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis. Lancet 344: 1105-1110.
16. Evans CH, Robbins PD 1996. Pathways to gene therapy in rheumatoid arthritis. Curr Opin Rheumatol 8: 230-234.
17. Feldmann M, Brennan FM, Maini RN 1996. Rheumatoid Arthritis. Cell 85: 307-310.
18. Fisher GH, Rosenberg FJ, Straus SE, Dale JK, Middelton LA, Yin AY, Strober W, Lenardo MJ, Puck JM 1995. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81: 935-946.
19. Fujisawa K, Aono H, Hasunuma T, Yamamoto K, Mita S, Mishioka K 1996. Activation of transcription factor NF-kB in human synovial cells in response to tumor necrosis factor-α. Arthritis Rheum 39: 197-203.
20. Jorgensen C, Gay S 1998. Gene therapy in osteoarticular diseases: where are we? Immunol Today 19: 387-391.
21. Kerr WG, Mulé JJ 1994. Gene therapy: current status and future prospects. J Leuk Biol 56: 210-214.
22. Kobayashi T, Okamoto K, Kobata T, Hasunuma T, Kato T, Hamada H, Nishioka K 2000. Novel gene therapy for rheumatoid arthritis by FADD gene transfer: induction of apoptosis of rheumatoid synoviocytes but not chondrocytes. Gene Ther 7: 527-533.
23. Lenardo MJ 1997. The molecular regulation of lymphocyte apoptosis. Sem Immunol 9: 1-5.
24. Lubberts E, Joosten LAB, van den Bersselaar L, Helsen MM, Bakker AC, van Meurs JBJ, Graham FL, Richards CD, van den Berg WB 1999. Adenoviral vector-mediated overexpression of IL-4 in the knee joint of mice with collagen-induced arthritis prevents cartilage destruction. J Immunol 163: 4546-4556.
25. Mageed RA, Adams G, Woodrow D, Podhajcer OL, Chernajovsky Y 1998. Prevention of collagen-induced arthritis by gene delivery of soluble p75 TNF receptor. Gene Ther 5: 1584-1592.
26. Makarov SS, Olsen JC, Johnston WN 1996. Suppression of experimental arthritis by gene transfer of IL-1 receptor antagonist cDNA. Proc Natl Acad Sci USA 93: 402-406.
27. Mauri C, Williams RO, Walmsley M, Feldmann M 1996. Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis. Eur J Immunol 26: 1511-1518.
28. McInnes IB, Leung BP, Sturrock RD, Field M, Liew FY 1997. Interleukin-15 mediates T-cell dependent regulation of tumor necrosis factor-α production in rheumatoid arthritis. Nat Med 3: 189-195.
29. Okamoto K, Asahara H, Kobayashi T, Matsuno H, Hasunuma T, Kobata T, Sumida T, Nishioka T 1998. Induction of apoptosis in rheumatoid synovium by Fas ligand gene transfer. Gene Ther 5: 331-338.
30. Oligino T, Ghivizzani SC, Wolfe D, Lechman ER, Krisky D, Mi Z, Evans CH, Robbins PD, Glorioso JC 1999. Intra-articular delivery of a herpes simplex virus IL1-Ra gene vector reduces inflammation in a rabbit model of arthritis. Gene Ther 6: 1713-1720.
31. Otani K, Nita I, Macaulay W, Georgescu HI, Robbins PD, Evans CH 1996. Suppression of antigen-induced arthritis by ex vivo gene therapy. J Immunol 156: 3558-3562.
32. Perillo NL, Pace KE, Seihamer JJ, Baum LG 1995. Apoptosis of T-cells mediated by galectin-1. Nature 378: 736-739.
33. Perillo NL, Uittenbogaart CH, Nguyen JT, Baum LG 1997. Galectin-1: an endogenous lectin produced by thymic epithelial cells, induces apoptosis of human thymocytes. J Exp Med 185: 1851-1858.
34. Quattrocchi E, Walmsley M, Browne K, Williams RO, Marinova-Mutafchieva L, Buurman W, Butler DM, Feldmann M 1999. Paradoxical effects of adenovirus-mediated blockade of TNF activity in murine collagen-induced arthritis. J Immunol 163: 1000-1009.
35. Rabinovich GA 1999a. Galectins: an evolutionarily conserved family of animal lectins with multifunctional properties; a trip from the gene to clinical therapy. Cell Death Diff 6: 711-721.
36. Rabinovich GA, Ariel A, Hershkoviz R, Hirabayashi J, Kasai K, Lider O 1999b. Specific inhibition of T-cell adhesion to extracellular matrix and pro-inflammatory cytokine secretion by human recombinant galectin-1. Immunology 97: 100-106.
37. Rabinovich GA, Aronso CR, Sotomayor CE, Durand S, Bocco JL, Riera CM 2000a. Molecular mechanisms implicated in galectin-1-induced apoptosis: activation of the AP-1 transcription factor and downregulation of Bcl-2. Cell Death Diff 7(8) (in press).
38. Rabinovich GA, Castagna LF, Landa C, Riera CM, Sotomayor CE 1996. Regulated expression of a 16-kd galectin-like protein in activated rat macrophages. J Leuk Biol 59: 363-370.
39. Rabinovich GA, Daly G, Dreja H, Tailor H, Riera CM, Hirabayashi J, Chernajovsky Y 1999c. Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis. J Exp Med 190: 385-397.
40. Rabinovich GA, Iglesias MM, Modesti NM, Castagna LF, Wolfenstein-Todel C, Riera CM, Sotomayor CE 1998. Activated rat macrophgaes produce a galectin-1-like protein that induces apoptosis of T cells: biochemical and functional characterization. J Immunol 160: 4831-4840.
41. Rabinovich GA, Modesti NM, Castagna LF, Landa CA, Riera CM, Sotomayor CE 1997. Specific inhibition of lymphocyte proliferation and induction of apoptosis by CLL-I, a β-galactoside-binding lectin. J Biochem 122:365-373.
42. Rabinovich GA, Riera CM, Iribarren P 1999d. Granulocyte-macrophage colony-stimulating factor protects dendritic cells from liposome-encapsulated dichloromethylene diphosphonate-induced apoptosis through a Bcl-2-mediated pathway. Eur J Immunol 29: 563-570.
43. Rabinovich GA, Riera CM, Landa CA, Sotomayor CE 1999e. Galectins: a key intersection between glycobiology and immunology. Braz J Med Biol Res 32: 383-393.
44. Rabinovich GA, Sotomayor CE, Riera CM, Bianco ID, Correa SG 2000b. Evidence of a role for galectin-1 in acute inflammation. Eur J Immunol 30: 1331-1339.
45. Ruchatz H, Leung BP, Wei X, Mclnnes IB, Liew FY 1998. Soluble IL-15 receptora-chain administration prevents collagen-induced arthritis: a role for IL-15 in development of antigen-induced immunopathology. J Immunol 160: 5654-5660.
46. Samucci EL, Fiourucci S, Cammilleri F, Servillo G, Federici B, Morelli A 2000. Galectin-1 exerts immunomodulatory and protective effects on concanavalin-A-induced hepatitis in mice. Hepatology 31: 399-406.
47. Singer GG, Carrera AC, Marshak-Rothstein A, Martinez AC, Abbas AK 1994. Apoptosis, Fas and systemic autoimmunity: the MRL-lpr/lpr model. Curr Opin Immunol 6: 913-920.
48. Song K, Chen Y, Göke R, Wilmen A, Seidel C, Göke A, Hilliard B, Chen Y 2000. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression. J Exp Med 191: 1095-1103.
49. Takayanagi H, Juji T, Miyazaki T, Iizuka H, Takahashi T, Isshiki M, Okada M, Tanaka Y, Koshihara Y, Oda H, Kurokawa T, Nakamura K, Tanaka S 1999. Suppression of arthritic bone destruction by adenovirus-mediated csk gene transfer to synoviocytes and osteoclasts. J Clin Inv 104: 137-146.
50. Taniguchi K, Kohsaka H, Inoue N, Terada Y, Ito H, Hirokawa K, Miyasaka N 1999. Induction of the p 16 INK4a senescence gene as a new therapeutic strategy for the treament of rheumatoid arthritis. Nat Med 5: 760-767.
51. Tomita T, Takeuchi E, Tomita N, Morishita R, Kaneko M, Yamamoto K, Nakase T, Seki H, Kato K, Kaneda Y, Ochi T 1999. Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor kB decoy oligodeoxynucleotides as a gene therapy. Arthritis Rheum 42: 2532-2542.
52. Vaishnaw AK, McNally JD, Elkon KB 1997. Apoptosis in the rheumatic diseases. Arthritis Rheum 40: 1917-1927.
53. Vespa GN, Lewis LA, Kozak KR, Moran M, Nguyen JT, Baum LG, Miceli MC 1999. Galectin-1 specifically modulates TCR signals to enhance TCR apoptosis but inhibits IL-2 production and proliferation. J Immunol 162: 799-806.
54. Weatherall DJ 1995. Scope and limitations of gene therapy. Br Med Bull 51: 1-11.
55. Williams RO, Feldmann M, Maini RN 1992, Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc Natl Acad Sci USA 89: 9784-9788.
56. Zhang H, Yang Y, Horton YL, Samoilova EB, Judge TA, Turka LA, Wilson JM, Chen Y 1997. Amelioration of collagen-induced arthritis by CD95 (Apo-1/Fas)-ligand gene transfer. J Clin Inv 100: 1951-1957.